Lack of transparency for Investigators in clinical trials: A bibliometric analysis of literature by Rohit Prasad

Get full text

Temporal trends in mental health terminology in Alzheimer’s disease clinical trials by Amir-Ali Golrokhian-Sani, Maya Morcos, Alecco Philippi, Reem Al-Rawi, Marc Morcos, Rui Fu

Get full text

Phases I–III Clinical Trials Using Adult Stem Cells by Ricardo Sanz-Ruiz, Enrique Gutiérrez Ibañes, Adolfo Villa Arranz, María Eugenia Fernández Santos, Pedro L. Sánchez Fernández, Francisco Fernández-Avilés

“…First randomized clinical trials have demonstrated that stem cell therapy can improve cardiac recovery after the acute phase of myocardial ischemia and in patients with chronic ischemic heart disease. …”
Get full text

Efficacy of MI Paste® on Bleaching-Related Sensitivity: Randomized Clinical Trial by Shaista Rashid, Mohamed ElSalhy

“…This randomized controlled split-mouth clinical trial included 45 subjects that were randomly divided into two groups. …”
Get full text

Patients’ Perceptions of their Participation in a Clinical Trial for Postoperative Crohn’s Disease by ED Kennedy, JE Blair, R Ready, BG Wolff, AH Steinhart, PW Carryer, RS McLeod

Get full text

Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies by Zinovia Kefalopoulou, Iciar Aviles-Olmos, Thomas Foltynie

“…Detailed evaluation of these discordant findings has highlighted several crucial issues such as patient selection criteria, details surrounding transplantation or gene therapy methodologies, as well as the study designs themselves that ought to be carefully considered in the planning phases of future clinical trials. Beyond the provision of symptomatic efficacy and safety data, it also remains to be identified whether the possibilities offered by stem cell and gene therapy technological advances might translate to meaningful neuroprotection and/or disease-modifying effects or alleviate the nonmotor aspects of PD and thus offer additional benefits beyond those achieved through conventional pharmacotherapy or deep brain stimulation (DBS).…”
Get full text

Conducting clinical trials with self-collection of pharmacokinetic samples: Experience from an exploratory, phase 1, open-label trial of centanafadine SR in healthy individuals by Chelsea Ye, Tatiana Shablinski, Susan E. Shoaf, Chris Chung, Michelle Bullock

Subjects: “…Alternative clinical trial design…”
Get full text

Developing a knowledge transfer and exchange strategy for a clinical trials unit by Annabelle South, Berta Terré Torras, Hannah Rush, Anna Goodman, Sharon Love

Subjects: Get full text

The role of social, economic, and medical marginalization in cancer clinical trial participation inequities: A systematic review by Grace Ann Hanvey, Hannah Johnson, Gabriel Cartagena, Duane E. Dede, Janice L. Krieger, Kathryn M. Ross, Deidre B. Pereira

Subjects: Get full text

Marine natural products as a source of novel anticancer drugs: an updated review (2019–2023) by Hesham R. El-Seedi, Mohamed S. Refaey, Nizar Elias, Mohamed F. El-Mallah, Faisal M. K. Albaqami, Ismail Dergaa, Ming Du, Mohamed F. Salem, Haroon Elrasheid Tahir, Maria Dagliaa, Nermeen Yosri, Hongcheng Zhang, Awg H. El-Seedi, Zhiming Guo, Shaden A. M. Khalifa

Subjects: Get full text

UK cancer vaccine advance – Recognising and realising opportunities by Charles Craddock, Philip Earwaker, Matthew Fittall, Elisa Fontana, Divya Ganesh, Marco Gerlinger, Qamar Ghafoor, Robert P Jones, Victoria Kunene, Lennard Lee, Rebecca Lee, Siow-Ming Lee, Mark Linch, Martin Little, Justin Liu, Hayley McKenzie, Russell Petty, David J Pinato, Thomas Powles, Andrew Protheroe, Tim Robinson, Paul J Ross, Kai Keen Shiu, James Spicer, Stefan Symeonides, Michael Tilby, Dale Vimalachandran, Jenny Y Wang, Andrew Wardley, Helen Winter

Subjects: Get full text

The Use of Electronic Consent (eConsent) Within the Ketamine for Long-Lasting Pain Relief After Surgery (KALPAS) Multicenter Trial by Doan LV, Burr J, Perez R, Martinez H, Cuevas R, Watt K, Wang J

Subjects: Get full text

Sociodemographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda by Isaac, Echoru, Patricia, Decanar Ajambo, Emmanuel, Keirania, Edmund E. M, Bukenya

Subjects: “…COVID-19, vaccine, Acceptance, Clinical trials, Western Uganda…”
Get full text

Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials by Zhao M, Zhang X, Zhou D, Song J

Subjects: Get full text

Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects by George G Zhanel, Andrew E Simor, Lavern Vercaigne, Lionell Mandell, the Canadian Carbapenem Discussion Group

Get full text

Use of the consort-ai protocol in reporting artificial intelligence applications in clinical trials by Mustafa Agah Tekindal, Melike Tekindal, Mert Demirsöz, Zeynep Özel

Get full text

CLINICAL TRIAL ASSESSING THE PREVALENCE OF ORAL COMPLICATION IN A DENTURE WEARERS POPULATION by Cosmin Bida, Doriana Agop-Forna, Dana Gabriela Budala, Norina Forna

Get full text

Cuban Public Registry of Clinical Trials: First of the World Health Organization in America by Olga Lidia Cuevas Pérez, Jayce Díaz Díaz, Mileydis López Bacallao

Get full text

Demographic clinical trial diversity assessment methods: Use of real-world data by Hua Chen, Nnadozie Emechebe, Sudeep Karve, Leon Raskin, Jailene Leal, Ning Cheng, Wendy Sebby, Kim Ribeiro, Samuel Crawford

Subjects: “…Clinical trial diversity…”
Get full text

Hydrophobic and Hydrophilic IOLs in Patients with Uveitis – A Randomised Clinical Trial by Pålsson S, Schuborg C, Sterner B, Andersson Grönlund M, Zetterberg M

Get full text